Assistance Publique - Hôpitaux de Paris: Leukemia trials

The registry lists 32 Leukemia studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 11 are open to participants now and 0 have results posted.

Phase 1 5Phase 2 11Phase 3 6No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid LeukemiaRecruitingNCT06225128
• Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study AnalysisRecruitingNCT06058858
• Clonal Hematopoiesis of Immunological SignificanceNot yet recruitingNCT05969821
• Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction StudiesRecruitingNCT05772559
• Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line TreatmentRecruitingNCT05580861Phase 1/2
• Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine HospitalNot yet recruitingNCT05558943
• The Patient Cohort of the National Center for Precision Medicine in LeukemiaRecruitingNCT05326919
• Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of PersistenceRecruitingNCT05310591Phase 1/2
• Single-cell Dynamic Profiling in Adults With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy. A THEMA Study"RecruitingNCT05304156
• Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell TransplantationNot yet recruitingNCT05054478Phase 2
• Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young AdultsRecruitingNCT02617004
• Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in PediatricsStatus unknownNCT05664230
• Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)Active, not recruitingNCT05237245
• Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their SiblingsCompletedNCT04969601Phase 1/2
• Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired ProtocolStatus unknownNCT04677231
• ETOILE : A Feasibility Study in Pediatric Patient EducationCompletedNCT04399863Not applicable
• Endothelial Activation Hemostasis Disturbances and Severe Bleeding Events in Hyperleukocytic Acute Myeloid LeukemiaStatus unknownNCT04133220
• MIF Involvement in AMLActive, not recruitingNCT03918655
• Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell AllograftStatus unknownNCT03887156Phase 2/3
• Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic LeukemiaActive, not recruitingNCT03709719Phase 2
• HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell TransplantationStatus unknownNCT03655145Phase 3
• Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive AspergillosisCompletedNCT03349931
• Observational Study of Patients Older Than 60 Years With Acute Myeloblastic LeukemiaStatus unknownNCT01966497
• Haploidentical NK-cell Infusion in Acute Myeloid LeukemiaCompletedNCT01947322Phase 1/2
• Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid LeukemiaCompletedNCT00797758Phase 2
• Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic LeukemiaCompletedNCT00773149Phase 1/2
• Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL PositiveCompletedNCT00763763Phase 2
• Timed-Sequential Induction in CBF-AMLCompletedNCT00428558Phase 3
• Acute Promyelocytic Leukemia 2006 (APL)Status unknownNCT00378365Phase 3
• 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDSCompletedNCT00339196Phase 2
• Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid LeukaemiaStatus unknownNCT00224614Phase 3
• Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2Status unknownNCT00149162Phase 3